Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Selank

Selanc, TP-7

Quick Stats
Studies 114
Trials 11
Score 2
2006 pubmed

[Comparison of anticoagulant effects of regulatory proline-containing oligopeptides. Specificity of glyprolines, semax, and selank and potential of their practical application].

Liapina. L A LA; Pastorova. V E VE; Obergan. T Iu TIu; Samonina. G E GE; Ashmarin. I P IP; Miasoedov. N F NF

Key Findings

  • Selank exhibits anticoagulant activity in experimental models
  • Glyprolines and semax have different, sometimes weaker, effects on coagulation
  • The peptide’s proline‑rich structure appears to drive its impact on hemostasis

Practical Outcomes

  • If you use selank, be aware it may modestly thin your blood, especially if you’re also taking blood‑thinners or have clotting issues. Monitor any signs of excessive bleeding and consider discussing use with a healthcare professional, but the study doesn’t provide specific dosing or protocol changes.

Summary

The paper compares how selank and similar proline‑rich peptides affect blood clotting, showing they each have distinct anticoagulant actions, with selank showing a measurable blood‑thinning effect.

Abstract

Experimental and theoretical demonstration of different effect of certain regulatory peptides (RPs) on blood coagulation is available. The problem of the role of RPs in hemostatic processes becomes particularly significant since, first, the peptides are widespread in nature both in animal and plant tissues, second, there is a relationship between the peptide structure and function and, third, both natural and synthetic peptides are used in practical medicine to correct functions of some factors of the hemostatic system. Many peptide inhibitors of the primary and plasma hemostasis potentiating anticoagulant effects in the body have been described.

Study Information

Provider

pubmed

Year

2006